The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer

被引:1034
|
作者
Kansanen, Emilia [1 ]
Kuosmanen, Suvi M. [1 ]
Leinonen, Hanna [1 ]
Levonen, Anna-Liisa [1 ]
机构
[1] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland
来源
REDOX BIOLOGY | 2013年 / 1卷 / 01期
基金
芬兰科学院;
关键词
Nrf2; Keap1; Cancer; Antioxidant response element; Gene therapy; NRF2; EFFICACY;
D O I
10.1016/j.redox.2012.10.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 activity provides growth advantage by increasing cancer chemoresistance and enhancing tumor cell growth. In this graphical review, we provide an overview of the Keap1-Nrf2 pathway and its dysregulation in cancer cells. We also briefly summarize the consequences of constitutive Nrf2 activation in cancer cells and how this can be exploited in cancer gene therapy. (C) 2013 The Authors. Published by Elsevier B.V.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 50 条
  • [41] Monitoring Keap1-Nrf2 interactions in single live cells
    Baird, Liam
    Swift, Sam
    Lleres, David
    Dinkova-Kostova, Albena T.
    BIOTECHNOLOGY ADVANCES, 2014, 32 (06) : 1133 - 1144
  • [42] KEAP1-NRF2 Interaction in Cancer: Competitive Interactors and Their Role in Carcinogenesis
    Oskomic, Marina
    Tomic, Antonija
    Barbaric, Lea
    Matic, Antonia
    Kindl, Domagoj Christian
    Matovina, Mihaela
    CANCERS, 2025, 17 (03)
  • [43] Immunoediting of KEAP1-NRF2 mutant tumours is required to circumvent NRF2-mediated immune surveillance
    Baird, Liam
    Yamamoto, Masayuki
    REDOX BIOLOGY, 2023, 67
  • [44] TMED2 Induces Cisplatin Resistance in Breast Cancer via Targeting the KEAP1-Nrf2 Pathway
    Liang, Chen
    Zhang, Han-yong
    Wang, Yi-qian
    Yang, Ling-ang
    Du, Yu-sen
    Luo, Ying
    Zhang, Tong-cun
    Xu, Yao
    CURRENT MEDICAL SCIENCE, 2023, 43 (05) : 1023 - 1032
  • [45] Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
    Orru, Claudia
    Perra, Andrea
    Kowalik, Marta Anna
    Rizzolio, Sabrina
    Puliga, Elisabetta
    Cabras, Lavinia
    Giordano, Silvia
    Columbano, Amedeo
    CANCERS, 2020, 12 (08) : 1 - 16
  • [46] TMED2 Induces Cisplatin Resistance in Breast Cancer via Targeting the KEAP1-Nrf2 Pathway
    Chen Liang
    Han-yong Zhang
    Yi-qian Wang
    Ling-ang Yang
    Yu-sen Du
    Ying Luo
    Tong-cun Zhang
    Yao Xu
    Current Medical Science, 2023, 43 : 1023 - 1032
  • [47] Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant
    Kageyama, Shun
    Saito, Tetsuya
    Obata, Miki
    Koide, Ryo-hei
    Ichimura, Yoshinobu
    Komatsu, Masaaki
    MOLECULAR AND CELLULAR BIOLOGY, 2018, 38 (07)
  • [48] KEAP1-NRF2 Pathway as a Novel Therapeutic Target for EGFR-Mutant Non-small Cell Lung Cancer
    Choi, Jae-Sun
    Kang, Hye-Min
    Na, Kiyong
    Kim, Jiwon
    Kim, Tae-Woo
    Jung, Junyang
    Lim, Heejin
    Seo, Hyewon
    Lee, Seung Hyeun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2025, 88 (01) : 138 - 149
  • [49] Therapeutic Effects of Natural Products in the Treatment of Chronic Diseases: The Role in Regulating KEAP1-NRF2 Pathway
    Li, Yaling
    Wang, Xijia
    Li, Shuyue
    Wang, Lei
    Ding, Ningning
    She, Yali
    Li, Changtian
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2025,
  • [50] The role of the KEAP1-NRF2 signaling pathway in form deprivation myopia guinea pigs
    Gu, Zhiming
    Meng, Jiayu
    Zhong, Weiqi
    Lan, Changjun
    Tan, Qingqing
    Xiang, Xiaoling
    Zhou, Hong
    Liao, Xuan
    BMC OPHTHALMOLOGY, 2024, 24 (01)